The DOI matches its Crossref record.
Hepatogastroenterology
Abstract
BACKGROUND/AIMS: Lysophosphatidic acid (LPA) has diverse biological activities implicated in tumor progression, including increasing cell migration, invasion and metastasis. However, the underlying mechanisms for LPA-induced human hepatocellular carcinoma (HCC) migration and invasion are poorly understood. METHODOLOGY: We sought to determine the promoting effect of LPA on HCC migration, invasion and adhesion by transwell and matrix adhesion assays, respectively. Levels of matrix metalloproteinase, MMP-2 and MMP- 9 from cells were assayed by ELISA and p38 mitogenactivated protein kinase (MAPK) signaling was determined by western blot analysis. RESULTS: In the present study, LPA was found to increase HCC cell migration, invasion and adhesion. In addition, LPA increased MMP-9 expression level and induced activation of the p38 mitogen- activated protein kinase (MAPK) signaling. Furthermore, pharmacological inhibition of p38 MAPK signal pathway with SB203580 significantly attenuated LPA-induced HCC cell migration, invasion, and adhesion and abrogated LPA-induced MMP-9 expression and p38 MAPK phosphorylation. CONCLUSIONS: We demonstrated a mechanism that LPA can activate p38 MAPK signaling, which is required for LPA-induced HCC cell migration, invasion, adhesion and MMP-9 expression, providing a novel biomarker and potential therapeutic target for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The secret ally: immunostimulation by anticancer drugs
Galluzzi, L., Senovilla, L., Zitvogel, L., & Kroemer, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3626 · Cited by 670
Laparoscopic Liver Resections: A Feasibility Study in 30 Patients
Cherqui, D., Husson, E., Hammoud, R., Malassagne, B., Stéphan, F., Bensaid, S., Rotman, N., & Fagniez, P.-L. (2000) · Annals of Surgery · doi:10.1097/00000658-200012000-00004 · Cited by 547
Blei, A. T., & Córdoba, J. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03964.x · Cited by 527
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462
Sewnath, M. E., Karsten, T. M., Prins, M. H., Rauws, E. J. A., Obertop, H., & Gouma, D. J. (2002) · Annals of Surgery · doi:10.1097/00000658-200207000-00005 · Cited by 419
Des Guetz, G., Uzzan, B., Nicolas, P., Cucherat, M., Morere, J.-F., Benamouzig, R., Breau, J.-L., & Perret, G.-Y. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603176 · Cited by 406
ESTES guidelines: acute mesenteric ischaemia
Tilsed, J. V. T., Casamassima, A., Kurihara, H., Mariani, D., Martinez, I., Pereira, J., Ponchietti, L., Shamiyeh, A., al-Ayoubi, F., Barco, L. A. B., et al. (2016) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-016-0634-0 · Cited by 382
Neuroplasticity and dysfunction after gastrointestinal inflammation
Brierley, S. M., & Linden, D. R. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.103 · Cited by 311
Tao, R., Krishnan, S., Bhosale, P. R., Javle, M. M., Aloia, T. A., Shroff, R. T., Kaseb, A. O., Bishop, A. J., Swanick, C. W., Koay, E. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.3778 · Cited by 309
Lipid alterations in chronic liver disease and liver cancer
Paul, B., Lewinska, M., & Andersen, J. B. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100479 · Cited by 308
Pawlik, T. M., Reyes, D. K., Cosgrove, D., Kamel, I. R., Bhagat, N., & Geschwind, J.-F. H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1021 · Cited by 304
Epidemiology of Gastroesophageal Reflux Disease in Asia: A Systematic Review
Jung, H.-K. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.1.14 · Cited by 257
Dose Adjustment in Patients with Liver Disease
Delc??, F., Tchambaz, L., Schlienger, R., Drewe, J., & Kr??henb??hl, S. (2005) · Drug Safety · doi:10.2165/00002018-200528060-00005 · Cited by 256
Efferocytosis in the tumor microenvironment
Werfel, T. A., & Cook, R. S. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0698-5 · Cited by 156
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome
Muratori, P., Granito, A., Pappas, G., Pendino, G. M., Quarneti, C., Cicola, R., Menichella, R., Ferri, S., Cassani, F., Bianchi, F. B., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.126 · Cited by 125
Pohl, J., Ring, A., Stremmel, W., & Stiehl, A. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00012 · Cited by 111
Circadian timing in cancer treatment: the biological foundation for an integrative approach
Lis, C. G., Grutsch, J. F., Wood, P., You, M., Rich, I., & Hrushesky, W. J. M. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403002002002 · Cited by 48
Bone health and vitamin D status in alcoholic liver disease
Kizilgul, M., Ozcelik, O., & Delibasi, T. (2016) · Indian Journal of Gastroenterology · doi:10.1007/s12664-016-0652-1 · Cited by 20
Cephalic phase of pancreatic polypeptide release: a valid test of autonomic neuropathy in diabetics
Glasbrenner, B., Brückel, J., Gritzmann, R., & Adler, G. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01153-6 · Cited by 17
Metadata
- Venue
- Hepatogastroenterology
- Publisher
- Update Medical Publishing
- Published
- 2011-10-24
- Volume
- 59
- Issue
- 115
- Pages
- 785-9
- ISSN
- 0172-6390 (ISSN-L)
- OpenAlex
- W142591619
- Cited by
- 953
- References
- 0
- Type
- paratext
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.